
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+5
PatenSee is a clinical-stage medical device company that has developed a contactless surveillance system designed to detect early developing asymptomatic vascular stenosis in hemodialysis patients. By harnessing advanced, multi-modal imaging technologies and Machine Learning, PatenSees aims to flag stenosis risk at the earliest stage, enabling care teams to perform simple interventions to protect the patients hemodialysis lifeline, improve quality of care and prolong life expectancy. PatenSee addresses the dialysis market, which is expected to exceed $100B by 2024. PatenSee is a seed stage portfolio company of MEDX Xelerator. PatenSee was founded by Hagay Drori and Oz Seadia following their participation...
Esdr,hemodialysis,vascular access stenosis ,bloodflow ,preventative care ,machine-learning ,renal care,medtech,innovation,and medical device
Patensee operates in the Medical equipment manufacturing industry.
Patensee's revenue is 11m - 100m
Patensee has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.